Fortrea Holdings (FTRE) Other Non-Current Liabilities (2022 - 2026)

Fortrea Holdings (FTRE) posted Other Non-Current Liabilities of $37.8 million for Q1 2026, down 3.82% on a QoQ basis from $39.3 million in Q4 2025, and up 4.13% year-over-year from $36.3 million in Q1 2025.

Fortrea Holdings (FTRE) Other Non-Current Liabilities (2022 - 2026) Analysis & Trends

Fortrea Holdings' Other Non-Current Liabilities history runs 5 years deep, the most recent figure standing at $37.8 million for Q1 2026.

  • Quarterly Other Non-Current Liabilities rose 4.13% year-over-year to $37.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $37.8 million (up 4.13% YoY) and the FY2025 annual result came in at $39.3 million, up 11.33% from the prior year.
  • Other Non-Current Liabilities was $37.8 million for Q1 2026 at Fortrea Holdings, down from $39.3 million in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $39.3 million in Q4 2025 and bottomed at $21.7 million in Q4 2022.
  • A 5-year average of $34.2 million and a median of $36.3 million in 2025 frame the typical range for Other Non-Current Liabilities.
  • Annual changes were most pronounced in 2023 — Other Non-Current Liabilities soared 47.93% — and 2024, when it decreased 20.0%.
  • Fortrea Holdings' Other Non-Current Liabilities stood at $21.7 million in 2022, then surged by 47.93% to $32.1 million in 2023, then climbed by 9.97% to $35.3 million in 2024, then climbed by 11.33% to $39.3 million in 2025, then fell by 3.82% to $37.8 million in 2026.
  • Business Quant data shows FTRE's Other Non-Current Liabilities at $37.8 million in Q1 2026, $39.3 million in Q4 2025, and $36.4 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn
7 Belite Bio 62.72 Bn 62.72 Bn -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn
9 Revolution Medicines 37.35 Bn 37.35 Bn -
10 Fortrea Holdings 1.79 Bn 1.64 Bn 123.60 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 37.80 Mn
Dec 31, 2025 39.30 Mn
Sep 30, 2025 36.40 Mn
Jun 30, 2025 37.00 Mn
Mar 31, 2025 36.30 Mn
Dec 31, 2024 35.30 Mn
Sep 30, 2024 37.60 Mn
Jun 30, 2024 29.60 Mn
Mar 31, 2024 28.90 Mn
Dec 31, 2023 32.10 Mn
Sep 30, 2023 35.70 Mn
Jun 30, 2023 37.00 Mn
Dec 31, 2022 21.70 Mn